Lenalidomide,Idecabtagene vicleucel,Daratumumab,Pomalidomide,Dexamethasone,Bortezomib,Ixazomib,Carfilzomib,Elotuzumab
BMS,2Seventy Bio,Janssen,takeda,AbbVie
['multiplemyeloma', '2seventy']
we re thrilled to be in frankfurt at #eha2023 presenting our latest clinical trial data in #multiplemyeloma. learn more about our presentations at eha: 
We think in the language of time and endeavor to outmaneuver #cancer so the people we serve can have MORE time.